Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma

Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma

Simon Heidegger,1 Ambros Beer,2 Eva Geissinger,3 Andreas Rosenwald,3 Christian Peschel,1 Ingo Ringshausen,1 Ulrich Keller11III Medical Department, 2Nuclear Medicine Department, Technische Universität München, Munich, Germany; 3Institute of Pathology, University of Würzbur...

Full description

Bibliographic Details
Main Authors: Heidegger S, Beer AJ, Geissinger E, Rosenwald A, Peschel C, Ringshausen I, Keller U
Format: Article
Language:English
Published: Dove Medical Press 2014-06-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/combination-therapy-with-brentuximab-vedotin-and-cisplatincytarabine-i-a17273

Internet

http://www.dovepress.com/combination-therapy-with-brentuximab-vedotin-and-cisplatincytarabine-i-a17273

Similar Items